Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373152 | 0.87 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNA | |
| SCHEMBL4816761 | 0.85 | LMNA (0.31) | ALDH1A1LMNA | |
| SCHEMBL1376669 | 0.84 | TSHR (0.43) | ALDH1A1TSHRTHRBLMNA | |
| SCHEMBL1373497 | 0.83 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBTHRACA12 | |
| SCHEMBL16467135 | 0.82 | HSD17B10 (0.32) | — | |
| SCHEMBL1376639 | 0.82 | CES2 (0.44) | ALDH1A1TSHRTHRB | |
| SCHEMBL1375496 | 0.82 | LMNA (0.39) | ALDH1A1TSHRLMNACA12CA1 | |
| SCHEMBL29311419 | 0.82 | SMN1; SMN2 (0.40) | ALDH1A1TSHRRAB9APOLB | |
| SCHEMBL1373199 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTHRALMNA | |
| SCHEMBL1376930 | 0.81 | CES2 (0.47) | ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037503-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| US-20240229350-A1 | Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-12031048-B2 | Ink set and recording method | SEIKO EPSON CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| US-11999863-B2 | White ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2024-06-04 | — | — | US | disclosed |
| US-20240158655-A1 | Pigment Printing Ink Jet Ink Composition And Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| US-20240124732-A1 | Ink Jet Ink Composition And Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-04-18 | — | — | US | disclosed |
| US-20240059924-A1 | Reaction Liquid For Pigment Printing, Ink Set, And Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| US-20240059917-A1 | Ink Jet Ink Composition And Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| US-11904615-B2 | Recording method and ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2024-02-20 | — | — | US | disclosed |
| US-11898043-B2 | Ink jet ink composition set and ink jet recording method | SEIKO EPSON CORPORATION | 2024-02-13 | — | — | US | disclosed |
| EP-2824150-B1 | Inkjet ink set and image forming method | FUJIFILM CORP (JP) | 2017-09-20 | — | — | EP | disclosed |
| EP-2902454-B1 | INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD | FUJIFILM CORP (JP) | 2017-04-19 | — | — | EP | disclosed |
| US-9346968-B2 | Ink composition, ink set, and image forming method | FUJIFILM CORPORATION (JP) | 2016-05-24 | — | — | US | disclosed |
| EP-2902454-A1 | INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD | Fujifilm Corporation (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20150175819-A1 | INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| EP-2837619-A1 | METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE | Idemitsu Kosan Co., Ltd (JP) | 2015-02-18 | — | — | EP | disclosed |
| EP-2824150-A1 | Inkjet ink set and image forming method | FUJIFILM Corporation (JP) | 2015-01-14 | — | — | EP | disclosed |
| US-8563495-B2 | Resist remover composition and method for removing resist using same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20110287995-A1 | RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | HACL2, APEH, NAAA | ALDH1A1 448/4885TSHR 1284/4885THRB 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.